Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119720) titled 'Effect of Esketamine Combined with Ropivacaine on Postoperative Recovery and Inflammatory Immune Response in Patients Undergoing Single-Port Laparoscopic Surgery under TAP Block' on March 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chengdu Integrated TCM&Western Medicine Hospital (Chengdu first people's Hospital)
Condition:
Pain
Intervention:
GroupT:0.2% Ropivacaine + NS, total 40 ml
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-03
Target Sample Size: GroupT:30;GroupE:30;
Countries of Recruitment:
China
To know more, visit https:/...